A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Phys...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2017.1328445 |
id |
doaj-19a6fd1af9134e728a383debc66d4ff0 |
---|---|
record_format |
Article |
spelling |
doaj-19a6fd1af9134e728a383debc66d4ff02020-11-25T03:27:17ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162017-01-015511800180510.1080/13880209.2017.13284451328445A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) menFatemeh Beiraghdar0Behzad Einollahi1Alireza Ghadyani2Yunes Panahi3Abbas Hadjiakhoondi4Mahdi Vazirian5Ali Salarytabar6Behrad Darvishi7Baghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesTehran University of Medical SciencesTehran University of Medical SciencesBreast Cancer Research Center ACECRBreast Cancer Research Center ACECRContext: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm3 were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.http://dx.doi.org/10.1080/13880209.2017.1328445ipss scorequality of lifeprostate volumeextant urine volume |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fatemeh Beiraghdar Behzad Einollahi Alireza Ghadyani Yunes Panahi Abbas Hadjiakhoondi Mahdi Vazirian Ali Salarytabar Behrad Darvishi |
spellingShingle |
Fatemeh Beiraghdar Behzad Einollahi Alireza Ghadyani Yunes Panahi Abbas Hadjiakhoondi Mahdi Vazirian Ali Salarytabar Behrad Darvishi A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men Pharmaceutical Biology ipss score quality of life prostate volume extant urine volume |
author_facet |
Fatemeh Beiraghdar Behzad Einollahi Alireza Ghadyani Yunes Panahi Abbas Hadjiakhoondi Mahdi Vazirian Ali Salarytabar Behrad Darvishi |
author_sort |
Fatemeh Beiraghdar |
title |
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men |
title_short |
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men |
title_full |
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men |
title_fullStr |
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men |
title_full_unstemmed |
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men |
title_sort |
two-week, double-blind, placebo-controlled trial of viola odorata, echium amoenum and physalis alkekengi mixture in symptomatic benign prostate hyperplasia (bph) men |
publisher |
Taylor & Francis Group |
series |
Pharmaceutical Biology |
issn |
1388-0209 1744-5116 |
publishDate |
2017-01-01 |
description |
Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm3 were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH. |
topic |
ipss score quality of life prostate volume extant urine volume |
url |
http://dx.doi.org/10.1080/13880209.2017.1328445 |
work_keys_str_mv |
AT fatemehbeiraghdar atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT behzadeinollahi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT alirezaghadyani atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT yunespanahi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT abbashadjiakhoondi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT mahdivazirian atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT alisalarytabar atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT behraddarvishi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT fatemehbeiraghdar twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT behzadeinollahi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT alirezaghadyani twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT yunespanahi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT abbashadjiakhoondi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT mahdivazirian twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT alisalarytabar twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen AT behraddarvishi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen |
_version_ |
1724588556960137216 |